Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 15/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.38 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.38 |
| ▸ | CLPP | Q16740 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10225119 | 0.92 | CYP3A4 (0.36) | CYP3A4ALDH1A1ITGB1ITGA5CLPP | |
| SCHEMBL748754 | 0.91 | ALDH1A1 (0.39) | CYP3A4ALDH1A1ITGB1ITGA5CLPP | |
| SCHEMBL13369155 | 0.91 | ALDH1A1 (0.37) | CYP3A4ALDH1A1CLPP | |
| SCHEMBL13369156 | 0.89 | CYP3A4 (0.48) | CYP3A4 | |
| SCHEMBL12034932 | 0.89 | CLPP (0.38) | CYP3A4ALDH1A1CLPPTSHR | |
| SCHEMBL746033 | 0.88 | ALDH1A1 (0.39) | CYP3A4ALDH1A1ITGB1ITGA5CLPP | |
| SCHEMBL749196 | 0.88 | ALDH1A1 (0.39) | CYP3A4ALDH1A1ITGB1ITGA5CLPP | |
| SCHEMBL12153821 | 0.88 | ALDH1A1 (0.39) | CYP3A4ALDH1A1ITGB1ITGA5CLPP | |
| SCHEMBL749208 | 0.88 | ALDH1A1 (0.39) | CYP3A4ALDH1A1ITGB1ITGA5TSHR | |
| SCHEMBL13184819 | 0.87 | CYP3A4 (0.45) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070043052-A1 | Reverse-turn mimetics and method relating thereto | CHOONGWAE PHARMA CORPORATION (KR) | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070043052-A1 | Reverse-turn mimetics and method relating thereto | WNT1, APC, WNT3 | CYP3A4 4757/4885ALDH1A1 4305/4885ITGB1 4214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.